Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

NCT07215611 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT07215611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07215611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
September 2, 2025
Completion date
October 2, 2030
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone sarcomas, financial toxicity